XML 91 R77.htm IDEA: XBRL DOCUMENT v3.22.2
Segment Information (Schedule of Business Segments) (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Segment Reporting Information [Line Items]          
Net sales $ 2,486 $ 2,198 $ 5,024 $ 3,996  
Other (charges) gains, net (Note 14) 1 (3) 0 3  
Operating profit (loss) 483 567 1,014 893  
Equity in net earnings (loss) of affiliates 60 37 116 66  
Depreciation and amortization 103 91 209 181  
Capital expenditures 132 [1] 113 [1] 246 [2] 186 [2]  
Goodwill and intangible assets, net 2,023   2,023   $ 2,147
Total assets 12,713   12,713   11,975
Increase (decrease) in accrued capital expenditures 8 3 (15) (16)  
Engineered Materials          
Segment Reporting Information [Line Items]          
Net sales 948 682 1,858 1,327  
Acetate Tow          
Segment Reporting Information [Line Items]          
Net sales 119 138 244 257  
Acetyl Chain          
Segment Reporting Information [Line Items]          
Net sales [3] 1,419 1,378 2,922 2,412  
Operating Segments [Member] | Engineered Materials          
Segment Reporting Information [Line Items]          
Net sales 948 682 1,858 1,327  
Other (charges) gains, net (Note 14) 1 (1) 0 6  
Operating profit (loss) 166 123 290 253  
Equity in net earnings (loss) of affiliates 53 32 102 57  
Depreciation and amortization 45 35 91 70  
Capital expenditures 35 33 65 56  
Goodwill and intangible assets, net 1,613   1,613   1,714
Total assets 5,702   5,702   5,363
Operating Segments [Member] | Acetate Tow          
Segment Reporting Information [Line Items]          
Net sales 119 138 244 257  
Other (charges) gains, net (Note 14) 0 0 0 0  
Operating profit (loss) (1) 24 3 40  
Equity in net earnings (loss) of affiliates 0 0 0 0  
Depreciation and amortization 10 9 21 19  
Capital expenditures 9 10 17 21  
Goodwill and intangible assets, net 152   152   154
Total assets 1,136   1,136   1,098
Operating Segments [Member] | Acetyl Chain          
Segment Reporting Information [Line Items]          
Net sales 1,456 1,409 2,994 2,465  
Other (charges) gains, net (Note 14) 0 0 0 0  
Operating profit (loss) 429 516 928 767  
Equity in net earnings (loss) of affiliates 3 2 7 4  
Depreciation and amortization 42 43 87 84  
Capital expenditures 78 65 140 98  
Goodwill and intangible assets, net 258   258   279
Total assets 4,537   4,537   4,428
Corporate, Non-Segment [Member] | Other Activities          
Segment Reporting Information [Line Items]          
Net sales 0 0 0 0  
Other (charges) gains, net (Note 14) 0 (2) 0 (3)  
Operating profit (loss) (111) (96) (207) (167)  
Equity in net earnings (loss) of affiliates 4 3 7 5  
Depreciation and amortization 6 4 10 8  
Capital expenditures 10 5 24 11  
Goodwill and intangible assets, net 0   0   0
Total assets 1,338   1,338   1,086
Eliminations [Member]          
Segment Reporting Information [Line Items]          
Net sales (37) [4] (31) [4] (72) [5] (53) [5]  
Other (charges) gains, net (Note 14) 0 0 0 0  
Operating profit (loss) 0 0 0 0  
Equity in net earnings (loss) of affiliates 0 0 0 0  
Depreciation and amortization 0 0 0 0  
Capital expenditures 0 0 0 0  
Goodwill and intangible assets, net 0   0   0
Total assets 0   0   $ 0
Eliminations [Member] | Acetyl Chain          
Segment Reporting Information [Line Items]          
Net sales $ 37 $ 31 $ 72 $ 53  
[1] Includes an increase in accrued capital expenditures of $8 million and $3 million for the three months ended June 30, 2022 and 2021, respectively.
[2] Includes a decrease in accrued capital expenditures of $15 million and $16 million for the six months ended June 30, 2022 and 2021, respectively.
[3] Excludes intersegment sales of $37 million and $31 million for the three months ended June 30, 2022 and 2021, respectively. Excludes intersegment sales of $72 million and $53 million for the six months ended June 30, 2022 and 2021, respectively.
[4] Includes intersegment sales primarily related to the Acetyl Chain.
[5] Includes intersegment sales primarily related to the Acetyl Chain.